Development of novel immuno-gene therapy for gastrointestinal cancer using antigen presenting function of heat shock protein
利用热休克蛋白的抗原呈递功能开发新型胃肠癌免疫基因疗法
基本信息
- 批准号:10671132
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The anti-tumor effect of heat-shock proteins (hsp) derived from CMS7-ME tumor was investigated. CMS7-ME, cell line was established by a HER2/neu transduction into the CMS7 derived from BALB/c mice fibrosarcoma. Three kinds of hsps, gp-96, hsp-70, hsp-90 were extracted from CMS7-ME and subcutaneously inoculated into the other mice. CMS7-ME tumor was implanted into these hsp-immunized mice. In gp96 or hsp-70 treated group, growth inhibitory effect implanted of CMS7-ME was observed. There is no anti-tumor effect in hsp-90 treated group.In the model of CT-26, N-nitroso-N-methylurethane induced BALB/c colonic tumor, an anti-tumor effect of CT-26 derived hsps was investigated, gp-96 derived from CT-26 showed growth inhibitory effect to CT-26 tumor. There is no growth inhibitory effect of CT-26 derived hsp-70 or hsp-90 treated groups. The complex of gp96 extracted from normal liver and CT-26 specific peptide, AH-1 showed anti-tumor effect in this model. However an induction of AH-1 specific cytotoxic T cells was not detected in this experiment.Anti-tumor effect of dendritic cells (DC) pulsed with gp96 derived from CT-26 was compared with that of DC pulsed with AH-1. DC pulsed with gp96 derived from CT-26 showed more significant growth inhibitory effect to CT-26 tumor in comparison with AH-1 pulsed DC.These results suggest that the role of tumor derived hsp in the antigen presenting process.Further investigation would be required to confirm the mechanisms of these effects as a pre-clinical investigation.
研究了CMS 7-ME肿瘤热休克蛋白(heat-shock proteins,hsp)的抗肿瘤作用。将HER 2/neu基因导入BALB/c小鼠纤维肉瘤细胞株CMS 7,建立CMS 7-ME细胞系。从CMS 7-ME中提取三种热休克蛋白gp-96、hsp-70、hsp-90,分别接种于其他小鼠皮下。将CMS 7-ME肿瘤植入这些hsp免疫的小鼠中。在gp 96或hsp-70处理组中,观察到植入CMS 7-ME的生长抑制作用。在CT-26、N-亚硝基-N-甲基氨基甲酸乙酯诱导的BALB/c小鼠结肠肿瘤模型中,研究了CT-26来源的hsps的抗肿瘤作用,CT-26来源的gp-96对CT-26肿瘤具有生长抑制作用。CT-26衍生的hsp-70或hsp-90处理组没有生长抑制作用。从正常肝脏中提取的gp 96与CT-26特异性肽AH-1的复合物在该模型中显示出抗肿瘤作用。比较了CT-26来源的gp 96致敏的DC和AH-1致敏的DC的抗肿瘤作用。与AH-1相比,CT-26来源的gp 96致敏的DC对CT-26肿瘤的生长抑制作用更明显,提示肿瘤来源的hsp在抗原提呈过程中起重要作用,其作用机制有待于进一步的临床前研究。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kiniwa, Y, Fujita T, Akada M, Ito K, Shofuda T, Suzuki Y, Yamamoto A, Saida T, and Kawakami Y: "Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma"Cancer Res.. 61. 7900-7907 (2001)
Kiniwa, Y, Fujita T, Akada M, Ito K, Shofuda T, Suzuki Y, Yamamoto A, Saida T, 和 Kawakami Y:“从患有白癜风和 T 细胞浸润的黑色素瘤的患者中分离出肿瘤抗原”Cancer Res..
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
河上 裕: "抗腫瘍免疫"実験医学別冊「Bio Science新用語ライブラリー 免疫 第2版」. 242-244 (2000)
川上丰:《抗肿瘤免疫学》实验医学特刊《生物科学新术语库免疫学第2版》242-244(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kawakami Y, Wang X, Shofuda T, Sumimoto H, Tupesis JP, Fitzgerald E, Rosengerg SA: "Isolation of a new melanoma antigen, MAR-2, Containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes"Immunol.. 66(4). 2871-2877 (2001)
Kawakami Y、Wang X、Shofuda T、Sumimoto H、Tupesis JP、Fitzgerald E、Rosengerg SA:“分离出一种新的黑色素瘤抗原,MAR-2,含有可被自体肿瘤浸润 T 淋巴细胞识别的突变表位”Immunol.. 66
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
北川雄光 他: "転移性腫瘍に対する免疫療法・免疫遺伝子治療の現況と展望"臨床科学. 54(2). 203-208 (1999)
Yumitsu Kitakawa 等人:“转移性肿瘤的免疫治疗和免疫基因治疗的现状和前景”临床科学 54(2) (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
河上 裕: "免疫系が認識するヒト腫瘍抗原"癌治療の新たな試み 新編II. 253-284 (2000)
Yutaka Kawakami:“免疫系统识别的人类肿瘤抗原”癌症治疗新方法新版 II 253-284 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KITAGAWA Yuko其他文献
KITAGAWA Yuko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KITAGAWA Yuko', 18)}}的其他基金
Construction of platform for clinical application of cancer omics data
癌症组学数据临床应用平台构建
- 批准号:
20H03747 - 财政年份:2020
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Metabolic status of sentinel lymph node from gastrointestinal cancer
胃肠癌前哨淋巴结的代谢状态
- 批准号:
22390263 - 财政年份:2010
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel trans-lymphatic chemotherapy targeted to micrometastasis in sentinel lymph nodes using a phospholipids polymer-paclitaxel conjugate
使用磷脂聚合物-紫杉醇缀合物开发针对前哨淋巴结微转移的新型经淋巴化疗
- 批准号:
16591352 - 财政年份:2004
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Fundamental Research for Intervention of Poor Prognostic Factors and Strengthening of Surgical Care System for Gastrointestinal Cancer in Community Medicine
社区医学中胃肠癌不良预后因素干预和加强外科护理体系的基础研究
- 批准号:
23K16289 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigation of the oncogenic mechanism of novel oncogene SETDB1 in gastrointestinal cancer
新癌基因SETDB1在胃肠道癌中的致癌机制研究
- 批准号:
23K08116 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analysis of BAP1 in the control of gastrointestinal cancer progression and metastasis.
BAP1在控制胃肠癌进展和转移中的功能分析。
- 批准号:
23K08126 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analysis of inflammation-inducing bacteria derived form oral microflora and immunoreactive T cells in gastrointestinal cancer
胃肠癌中口腔微生物群和免疫反应性 T 细胞衍生的炎症诱导细菌的功能分析
- 批准号:
23K08201 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation
通过粪便 DNA 甲基化进行多部位胃肠癌检测
- 批准号:
10443018 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Improving Diagnosis in Gastrointestinal Cancer: Integrating Prediction Models into Routine Clinical Care
改善胃肠癌的诊断:将预测模型纳入常规临床护理
- 批准号:
10641060 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Study on fibrotic niche generation for promotion of gastrointestinal cancer metastasis
纤维化微环境生成促进胃肠癌转移的研究
- 批准号:
22KF0154 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of AI-based hospital stay management support system - Perioperative DPC data exploration for gastrointestinal cancer
基于AI的住院管理支持系统开发——消化道肿瘤围手术期DPC数据探索
- 批准号:
22K10407 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Systematic liquid biopsy to monitor residual disease and treatment efficacy in gastrointestinal cancer patients
系统液体活检监测胃肠道癌症患者的残留病灶和治疗效果
- 批准号:
10697368 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Analysis of the mechanism of acquisition of anticancer drug resistance using gastrointestinal cancer organoids
胃肠道肿瘤类器官获得抗癌耐药性的机制分析
- 批准号:
22K07013 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)